Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Diagnostic problems of Conn's adenomas]

B Charbonnel

Presse Medicale (Paris, France : 1983)

|January 22, 1998

Summary

Diagnosing primary hyperaldosteronism requires strict adherence to testing protocols. CT-scan and radiocholesterol scintigraphy are complementary imaging tools for confirming the diagnosis and determining etiology.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Efficacy and adherence of glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes mellitus in real-life settings.

Diabetes & metabolism·2019

Same author

Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL versus glargine 100 U/mL: A patient-level meta-analysis examining older and younger adults with type 2 diabetes.

Diabetes & metabolism·2018

Same author

After the LEADER trial and SUSTAIN-6, how do we explain the cardiovascular benefits of some GLP-1 receptor agonists?

Diabetes & metabolism·2017

Same author

Predicting severe hypoglycaemia with self-monitoring of blood glucose in type 1 diabetes.

Diabetes & metabolism·2017

Same author

Short-term effect of severe hypoglycaemia on glycaemic control in the Diabetes Control and Complications Trial.

Diabetes & metabolism·2016

Same author

Which oral antidiabetic drug to combine with metformin to minimize the risk of hypoglycemia when initiating basal insulin?: A randomized controlled trial of a DPP4 inhibitor versus insulin secretagogues.

Diabetes research and clinical practice·2016

Area of Science:

Endocrinology
Internal Medicine

Background:

Primary hyperaldosteronism (PHA) diagnosis relies on hormone assays and imaging, but adherence to testing protocols, including natriuresis and antihypertensive withdrawal, presents challenges.
Potassium levels are a useful screening indicator, though normokalemic PHA exists; the aldosterone/renin ratio is recommended for specific hypertensive patient groups.

Discussion:

Pseudohyperaldosteronism, caused by mineralotropic substances other than aldosterone, represents an uncommon but notable diagnostic consideration.
Differentiating between Conn's adenoma (requiring surgery) and hyperplasia (managed medically) is crucial once PHA is diagnosed.

Key Insights:

CT-scan and radiocholesterol scintigraphy with dexamethasone stimulation demonstrate comparable sensitivities in diagnosing PHA.
These imaging modalities are highly complementary, especially in complex or challenging diagnostic cases.
Accurate etiological determination through imaging is fundamental for guiding appropriate treatment strategies.

Outlook:

Further refinement of diagnostic protocols may improve early detection rates of primary hyperaldosteronism.
Integration of advanced imaging techniques can enhance diagnostic accuracy and therapeutic decision-making in endocrine hypertension.
Continued research into pseudohyperaldosteronism syndromes may reveal novel diagnostic and therapeutic approaches.

Related Experiment Videos